Refreshing results…
A Protein-Based, Long-Acting HIV-1 Fusion Inhibitor with an Improved Pharmacokinetic Profile
Download from doi.orgAn amphipathic peptide targeting the gp41 cytoplasmic tail kills HIV-1 virions and infected cells
UploadMissing publications? Search for publications with a matching author name.